Infinity Pharmaceuticals | INFI - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
AbbVie USD -3.27B 628M 2025-12
Alterity Therapeutics Limited AUD 36.21M 18.58M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Cipla INR 329.19B 16.3B 2025-09
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 102.73M 58.9M 2025-12
CSL USD 18.66B 2.75B 2025-12
Eisai JPY 889.64B 35.21B 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Grifols EUR 6.21B 133.12M 2025-12
Incyte USD 5.17B 516.28M 2025-12
Infinity Pharmaceuticals USD -37.41M 9.08M 2023-06
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
J&J USD 81.54B 3.07B 2025-12
Novartis USD 46.13B 1.38B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Plus Therapeutics USD 4M 1.06M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
TG Therapeutics USD 648.02M 40.8M 2025-12